Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: FLSC Phase I & II Clinical Trials |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-11-01 |
| Study Made Public: | 2015-02-03 |
Title
Investigation study into the immunogencity of various adjuvants in pursuit of a FLSC HIV vaccine
Description
CAVD 392 is a non-human primate study to evaluate and compare the immunogenicity of different adjuvants in combination with the immunogen, rhFLSC.
Sign in to see full information about this study and to download study data.
Products
rhFLSC Protein Alum IDRI EM001 GLA-SE (IDRI-EM005) Alum/GLA NoneIntegrated data
ICS, ELISpot, NAb
Non-integrated data
No non-integrated data is available for this study.